Invivyd, Inc. (IVVD) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Invivyd, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.012 Good day and welcome to the second quarter in Vivid Earnings Conference call. 00:00:04.012 -- 00:00:07.374 At this time, all participants are in listen-only mode. 00:00:07.374 -- 00:00:10.996 After the speaker's presentation, there will be a question and answer session. 00:00:10.996 -- 00:00:15.159 Instructions will be given at that time. As a reminder, this call may be recorded. 00:00:15.159 -- 00:00:17.159 I'd 00:00:17.380 -- 00:00:22.104 now like to turn the call over to Katie Falzone, Vice President, Corporate Controller. 00:00:22.104 -- 00:00:23.851 Please go ahead. 00:00:23.851 -- 00:00:28.654 Thank you, operator. A short while ago, we issued a press release announcing 00:00:28.654 -- 00:00:31.856 our Q2 2024 financial results and recent business highlights. 00:00:31.856 -- 00:00:35.438 That press release and the slides that are being used in today's webcast can be found 00:00:35.438 -- 00:00:39.301 in the investor section of the InVivid website under the press releases and events and 00:00:39.301 -- 00:00:42.502 presentation sections, respectively. 00:00:42.543 -- 00:00:46.566 Today's discussion will be led by Mark Aulia, chairperson of InVivid's board of directors 00:00:46.566 -- 00:00:49.267 and chairperson of the executive committee of the board. 00:00:49.267 -- 00:00:55.099 He is joined by Tim Lee, chief commercial officer, Bill Duke, Chief Financial Officer, 00:00:55.099 -- 00:00:58.359 Dr. Robert Allen, Chief Scientific Officer, and Dr. 00:00:58.359 -- 00:01:03.560 Mark Winterson, Senior Vice President of Clinical Development and Medical Affairs. 00:01:03.560 -- 00:01:07.301 During today's discussion, we will be making forward-looking statements concerning, among 00:01:07.301 -- 00:01:11.502 other things, our corporate...